Detectable minimal residual disease before hematopoietic
cell transplantation is prognostic but does not preclude
cure for children with very-high-risk leukemia
by Wing Leung, Ching-Hon Pui, Elaine Coustan-Smith, Jie Yang, Deqing Pei, Kwan
Gan, Ashok Srinivasan, Christine Hartford, Brandon M. Triplett, Mari Dallas, Asha
Pillai, David Shook, Jeffrey E. Rubnitz, John T. Sandlund, Sima Jeha, Hiroto Inaba,
Raul C. Ribeiro, Rupert Handgretinger, Joseph H. Laver, and Dario Campana
Blood
Volume 120(2):468-472
July 12, 2012
©2012 by American Society of Hematology
Survival and cumulative incidence of relapse after HCT stratified by MRD level.
Wing Leung et al. Blood 2012;120:468-472
©2012 by American Society of Hematology
Survival probability based on the level of MRD stratified by treatment era.
Wing Leung et al. Blood 2012;120:468-472
©2012 by American Society of Hematology
Survival probability based on the level of MRD stratified by leukemia type and treatment era.
Wing Leung et al. Blood 2012;120:468-472
©2012 by American Society of Hematology